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Structured Summary  
 
Objectives: To report the short and long-term outcomes of one or two-staged suture 
attenuation for complete closure of intrahepatic congenital portosystemic shunts (IHCPSS) in 
dogs. 
 
Methods: A retrospective cohort study of dogs surgically treated for IHCPSS between February 
2000 and March 2015 was performed. Long-term follow-up was obtained by telephone 
conversations with the referring veterinary surgeon and / or the owner. 
 
Results: Fifty-five dogs had suture attenuation of their IHCPSS. Ten dogs (18.2%) tolerated 
complete attenuation, whilst 45 dogs (81.8%) tolerated partial attenuation. Post-operative 
complications occurred in 24 dogs (43.6%), with six dogs (10.9%) dying.  Repeat surgery was 
performed in 33/39 dogs (84.6%) that had partial attenuation and 27 of these (84.9%) 
ultimately achieved complete CPSS attenuation. One dog (3.0%) died following second surgery, 
resulting in an overall post-operative mortality of 7/55 (12.7%). Detailed follow-up was 
available for 22 dogs that were still alive at a median of 29 months’ post-surgery (7.4-103.1) 
with a subjectively good quality of life. Fourteen out of 17 dogs (82.4%) with complete 
attenuation in one or two surgeries had an excellent outcome compared with 1/5 dogs (20%) 
with persistent shunting. 
 
Clinical Significance: Staged suture ligation resulted in a good rate of complete attenuation and 
a reduced rate of persistent shunting compared with a single surgery. Repeat surgery was 
associated with a lower complications rate compared to first surgery. The proportion of dogs 
with an excellent outcome was greater for those that had complete attenuation in one or two 
surgeries compared to those with persistent shunting. 
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Introduction 
Intrahepatic congenital portosystemic shunts (CPSS) are seen less commonly in dogs 
than their extrahepatic counterparts, making up approximately 25-33% of the total 
(Berent and Tobias 2009, Berent and Tobias 2012).  For both types of CPSS surgical 
attenuation is recommended to restore normal portal blood flow and resolve clinical 
signs (Berent and Tobias 2009, Tivers et al. 2012, Greenhalgh et al. 2014, Tivers et al. 
2017). However, intrahepatic CPSS (IHCPSS) can be challenging to manage surgically 
due to the location of the vessel within the liver parenchyma (Hunt et al. 1996, White et 
al.  1998, Berent and Tobias 2009). Surgical techniques for IHCPSS include suture 
ligation, ameroid constrictors, cellophane banding and hydraulic occluders (White et al. 
1998, Hunt et al. 2004, Kummeling et al. 2004, Adin et al. 2006, Bright et al. 2006, Mehl 
et al.  2007). Intravascular techniques with hepatic inflow occlusion have been used to 
allow attenuation of some IHCPSS, which is technically demanding (Breznock et al. 
1983, Hunt et al. 1996, White et al. 1998). Some studies have reported a high rate of 
complications (47-77%) and mortality (12.5-27.3%) with surgical attenuation of 
IHCPSS (Komtebedde et al. 1991, White et al. 1998, Papazoglou et al. 2002, Hunt et al. 
2004). Hence, intravascular occlusion with interventional radiology has been 
recommended to reduce complications and mortality associated with traditional 
surgical techniques (Weisse et al. 2014). However, there is limited long-term follow-up 
information on dogs with IHCPSS and only one comparative study, making the evidence 
base for choosing one technique over another even more challenging (Mehl et al. 2007, 
Tivers 2017).  
 
Only a minority of dogs (approximately 0-15.4%) can tolerate complete acute 
attenuation of their IHCPSS (Hottinger et al. 1995, White et al. 1998, Papazoglou et al. 
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2002, Kummeling et al. 2004). Dogs can be treated with partial attenuation but with this 
technique there remains a concern over residual shunting and the persistence or 
recurrence of clinical signs, which has been reported to be as high as 24.3-50% (Smith 
et al. 1995, White et al. 1998). Gradual attenuation devices such as ameroid constrictors 
and cellophane bands aim to achieve complete attenuation over a period of weeks 
(Hunt et al. 2004, Sereda and Adin 2005, Mehl et al. 2007). However, it is unclear how 
many dogs achieve complete attenuation and residual shunting may be present in a 
significant number of dogs (Mehl et al. 2007). Additionally, the technical challenge of 
placing a gradual attenuation device or material around an IHCPSS where the space 
around the shunt may be restricted can make placement impossible in some dogs. In 
dogs with IHCPSS or extrahepatic CPSS (EHCPSS) treated with partial suture ligation a 
second surgery has been described to attempt complete attenuation in a staged manner 
(Hottinger et al. 1995, White et al. 1998, Burton and White 2001, Lee et al. 2006). In 
three of these studies a proportion of dogs treated with partial attenuation had repeat 
surgery to attempt full ligation due to recurrence of clinical signs or persistently 
increased bile acids (Hottinger et al. 1995, White et al. 1998, Burton and White 2001). 
All 28 of the dogs treated with partial attenuation in one study (Lee et al. 2006) and 
9/27 dogs treated with partial ligation in another study (Hottinger et. al 1995) had a 
scheduled repeat surgery, without recurrence of clinical signs. The potential advantage 
of this technique is that it will ensure complete attenuation of the shunt and therefore 
reduce the chances of persistent or recurrent clinical signs associated with on-going 
shunting. However, this technique has not been reported in detail, particularly the 
complications and outcomes after the second surgery. 
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Staged suture ligation has been the routine treatment of IHCPSS in dogs the authors’ 
institution over the last 15 years. Subjectively this approach has been associated with a 
good short and long-term outcome. It was also our impression that the mortality rate 
had decreased with time, possibly associated with increased experience with surgical 
and anaesthetic management and the post-operative care. Historically dogs had been 
treated with non-steroidal anti-inflammatory drugs (NSAIDs) peri-operatively, to 
provide multi-modal analgesia. Subjectively the use of NSAIDs had been associated with 
mortality and their use had been discontinued.  
 
The aim of the current study was to report the short and long-term outcomes of one or 
two staged suture attenuation to achieve complete closure of IHCPSS in a large cohort of 
dogs. An additional aim was to report any changes in mortality associated with, age at 
surgery, time-period of the study and the use of NSAIDs.   
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Materials and Methods 
The medical records for dogs with IHCPSS treated surgically between February 2000 
and March 2015 were retrospectively reviewed. Dogs were included in the study if they 
had been treated with a complete or partial suture ligation of their IHCPSS. Dogs treated 
via other surgical methods were excluded. During the study period a standard surgical 
protocol was routinely followed in all dogs treated with suture ligation, although 
anaesthetic and post-operative management was at the discretion of the individuals 
involved.  
Dogs underwent laparotomy and intra-operative mesenteric portovenography (PVG) as 
previously described (Lee et al. 2006). The shunt was identified and the location that 
would provide the easiest access for ligation was determined, typically the shunt itself, 
the draining hepatic vein or the supplying portal vein branch. The vessel was dissected 
to allow two strands of 2m or 3m polypropylene (Prolene; Ethicon) or silk (Mersilk; 
Ethicon) suture material to be passed around it. A mesenteric vein was catheterised 
with a 20-24g over the needle catheter, which was used for portovenography and to 
measure portal venous pressure. Portovenography was performed using a mobile c-arm 
unit (Siremobil; Siemens) with a sterile cover. A bolus of 1ml/kg of iohexol contrast 
agent (Omnipaque 300; GE Healthcare Limited) was injected under fluoroscopic 
guidance, creating a series of portovenogram images. This allowed confirmation of 
portosystemic shunting and provided information on the morphology of the shunt and 
the intrahepatic portal vasculature.  The vessel was temporarily completely attenuated 
using a Rummel tourniquet and the portovenogram was repeated, allowing 
confirmation of correct location of attenuation and reassessment of the intrahepatic 
portal vasculature. Dogs were treated with complete or partial suture attenuation with 
polypropylene or silk (Lee et al. 2006, Cariou et al. 2009a). The degree of attenuation 
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was based on subjective and objective assessment of intra-operative portal 
hypertension during temporary complete attenuation. Subjective assessment was 
performed by visual inspection of the intestines and pancreas during temporary 
complete attenuation for signs of portal hypertension, including bowel hypermotility, 
increased mesenteric arterial pulsations, pancreatic oedema and intestinal and 
pancreatic cyanosis (Mathews and Gofton 1988). If these signs were observed, then it 
was considered that the dog would not tolerate a complete attenuation. Portal blood 
pressure was measured before and during temporary complete attenuation of the 
vessel using a pressure transducer (Becton Dickinson UK Limited) and a multi-
parameter monitor (S/5 Compact Monitor; GE Healthcare Limited) connected to the 
catheter in the mesenteric vein. The increase in portal pressure before and during 
temporary complete attenuation and the absolute portal pressure were used to 
determine whether complete attenuation could be performed (Bostwick and Twedt 
1995, Breznock et al. 1983, Butler et al. 1990, Swalec and Smeak 1990, Swalec et al. 
1991). Contraindications for complete attenuation were a post-attenuation portal 
pressure of >18mmHg (20cmH2O), an increase in >8 mmHg (10cmH2O) or a doubling of 
pre-attenuation portal pressure value. Additionally, a change in central venous pressure 
of >1mmHg or a change in arterial pressure of >5mmHg were considered contra-
indications to complete attenuation. 
Dogs treated with partial attenuation had a length of polypropylene suture left around 
the vessel to facilitate subsequent attenuation. A second surgery to attempt complete 
attenuation was recommended for all dogs that had partial attenuation, regardless of 
clinical response.  
Descriptive data was recorded from the medical record as presented in the results. The 
cohort was separated into two groups, with the first group being the initial 50% of the 
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dogs that had surgery and the second group being the subsequent 50%. The subjective 
response to medical management pre-surgery and the subjective short-term response 
to surgery, as described in the medical record, was graded by the primary author as 
follows: good = resolution of clinical signs, moderate = improvement in clinical signs, 
poor = no improvement in clinical signs or relapse. Intra-operative complications were 
defined as an adverse surgical event that required intervention to correct. Post-
operative complications were defined as an adverse event, occurring prior to hospital 
discharge. Complications were categorised into Neurological, Portal Hypertension, 
Gastrointestinal and Miscellaneous. Postoperative mortality was defined as those dogs 
that died or were euthanatized within 30 days of the surgery. This was further divided 
into those that died before or after hospital discharge.  
Detailed follow-up was available for a proportion of the dogs as part of another study 
using a Health-Related Quality of Life (HRQOL) questionnaire (currently unpublished 
data). Follow-up was obtained for the remaining dogs by telephone calls to the referring 
veterinary surgeon and / or owner. For dogs that were alive at the time of follow-up 
outcome was graded by the primary author based on the information obtained from the 
owner via the HRQOL questionnaire and telephone call. The grading was based on a 
previous study (Mehl et al. 2007): excellent = resolution of clinical signs and no medical 
management / diet, fair = resolution of clinical signs with continued medical 
management / diet, poor = recurrent or persistent clinical signs, no response to surgery. 
Owners were also asked to subjectively rate their dog’s quality of life. 
Statistical analysis was performed using a statistical software package (PASW Statistics 
21.0.0; Education SPSS (UK) Limited IBM, Woking, UK).  Data was assessed graphically 
for normality. Median and range were reported for skewed data. Categorical data were 
reported as percentages.  
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Results 
First surgery 
Fifty-five dogs met the inclusion criteria. The first 28 dogs were in the first half of the 
study period (February 2001 to November 2006) and the subsequent 27 dogs were in 
the second half of the study period (December 2006 to March 2015). Three dogs were 
excluded as they were treated with placement of a cellophane band around their CPSS. 
No dogs were treated with an ameroid constrictor, hydraulic occluder or endovascular 
coil embolization. Signalment data and pre-surgical information is presented in Table 1.  
 
Details of surgical variables are presented in Table 2. Fifty-four dogs were treated via an 
extravascular approach. The majority, including all left sided shunts, were ligated 
directly at their entry to the vena cava or via ligation of the draining hepatic vein. The 
remainder were treated via direct ligation of the shunt via dissection of the liver or via 
ligation of the portal vein branch supplying the shunt. One dog (central divisional CPSS) 
required an intravascular approach to shunt attenuation. Ten dogs (18.2%) tolerated a 
complete ligation and the remaining 45 dogs (81.8%) tolerated a partial ligation of their 
CPSS. Two dogs (3.6%) had an additional surgical procedure performed, one cystotomy 
and one gastric ulcer biopsy.  
 
Eight dogs (14.5%) suffered an intra-operative complication. All eight dogs tolerated 
partial attenuation only. Two dogs had an iatrogenic pneumothorax due to dissection of 
the shunt at the diaphragm. This was identified and treated during surgery. Two dogs 
had an apparent mild hypersensitivity reaction to pethidine, which was treated with a 
single intravenous dose of chlorpheniramine. Four dogs (7.3%) experienced intra-
operative haemorrhage. Three of these dogs (two left and one right divisional) 
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experienced haemorrhage during dissection of the shunt. These dogs all required a 
blood transfusion but this complication did not prevent attenuation.  The fourth dog 
(central divisional) experienced haemorrhage secondary to shunt dissection and the 
procedure was aborted without attenuation. This dog also required a blood transfusion. 
Partial attenuation was achieved at repeat surgery eight days later. 
 
Twenty-four dogs (43.6%) had a post-operative complication, with four of these dogs 
suffering two complications each (Table 3). Six out of 10 dogs (60%) that could tolerate 
a complete ligation and 18 /45 dogs (40%) that were treated with a partial ligation 
experienced a post-operative complication. Post-operative complications affected 
11/26 (42.3%) of dogs with a left divisional shunt, 4/15 (26.7%) of dogs with a right 
divisional shunt and 9/14 (64.3%) of dogs with a central divisional shunt. 
 
Four dogs (7.3%) died in the immediate postoperative period (see Table 3 for details). 
Fifty-one dogs (92.7%) were discharged from the hospital. The median duration of 
hospitalisation was four days (range 2-13). Two dogs (3.6%) died in the immediate 
period following discharge from the hospital (see Table 3 for details). Overall six dogs 
(10.9%) died within 30 days of surgery. All six dogs had tolerated a partial attenuation 
only. Six out of 45 dogs (13.3%) treated with partial attenuation died post-operatively 
compared with 0/10 dogs (0%) that had complete attenuation. The median age of dogs 
that died during the post-operative period was 6.2 months (range 2.4-29.1 months) 
compared with a median of 18.7 months (range 4.3-38.2) for dogs that survived. Five 
out of 28 dogs (17.9%) that had their surgery in the first part of the study period died 
during the post-operative period compared with 1/27 dogs (3.7%) that had their 
surgery in the second part of the study period. Five out of 13 dogs (38.5%) that received 
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NSAIDs died during the post-operative period (up to 30 days) compared with 1/42 dogs 
(2.4%) that did not receive NSAIDs. All four dogs that died because of confirmed or 
suspected gastroduodenal haemorrhage received NSAIDs. 
 
Second surgery 
Overall 39/45 dogs that were treated with partial attenuation survived the post-
operative period. Thirty-six out of the surviving 39 dogs (92.3%) were re-examined 
(see Table 4 for details). The other three dogs did not return for post-operative re-
examination.  
Thirty-three out of 39 dogs (84.6%) had a second surgery performed (see Table 5 for 
details). Three dogs were re-examined but the owners declined further surgery (two 
had a good response and one had a moderate response) and three did not return for 
post-operative re-examination.  
Twenty-four dogs (72.7%) still had some blood flow through the CPSS on PVG but were 
able to tolerate complete attenuation, two dogs (6.1%) still had blood flow through the 
CPSS on PVG but were only able to tolerate further partial attenuation (one due to the 
presence of extensive adhesions preventing further dissection and one due to portal 
hypertension), three dogs (9.1%) had progressed to full attenuation with no blood flow 
through the CPSS on PVG and four dogs (12.1%) had developed multiple acquired 
shunts. The CPSS had been ligated with prolene alone in the three dogs that progressed 
to full attenuation. Overall, 27 dogs (81.8%) out of 33, achieved full attenuation of their 
CPSS in two surgeries. This is summarised in Figure 1. 
Twenty-three dogs (69.7%) had another surgical procedure performed at the time of 
the second CPSS surgery, 15 ovariohysterectomy (OVH), six castration, one 
ovariectomy, and one entropion correction. Neutering was performed in all three of the 
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dogs that had progressed to full attenuation spontaneously and two of the dogs that had 
developed MAS.  
There was one intra-operative complication (3.0%) where it was not possible to achieve 
full attenuation due to the presence of marked adhesions following the previous 
surgery, although further attenuation was possible. Seven dogs (21.2%) suffered a 
postoperative complication (Table 6). No dogs died or were euthanatized in the 
immediate post-operative period with all 33 dogs surviving to be discharged from the 
hospital. The median duration of hospitalisation was four days (range 1-7). One dog that 
had developed MAS and could not tolerate further attenuation started showing 
neurological signs five days after the surgery, following discharge from the hospital.  
The dog was euthanatized later that day by the referring veterinary surgeon.  The 
overall post-operative mortality rate was 1/33 (3.0%). 
 
Short-term post-operative re-examination 
Eight out of 10 dogs (80%) that were treated with complete attenuation were re-
examined in the short-term post-surgery (two by the referring vet) (see table 7 for 
details). One dog with a good outcome has MAS identified on follow-up 
portovenography. 
 
Fourteen out of 32 dogs (43.8%) initially treated with partial attenuation and surviving 
their second shunt surgery, were re-examined in the short-term (three by the referring 
vet) (see table 8 for details). Two dogs had further attenuation of their shunt at a third 
surgery as follows. One dog with a moderate response to surgery had persistent 
shunting on portovenography and further partial attenuation was performed. Complete 
attenuation was subsequently achieved at an additional surgery. Another dog with a 
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good outcome had a very minimal amount of shunting on portovenography, performed 
at the same time as OVH, and this was treated with complete attenuation. In addition, 
one dog with a complete attenuation at their second surgery and a good response had 
MAS documented on a follow-up ultrasound scan. 
 
Long-term Follow-up 
Of the 48 dogs that survived surgery, 13 dogs (27.1%) were lost to long-term follow-up. 
Twenty-five out of 35 dogs (52.1%) were alive at a median follow-up of 33.5 months 
(range 7.4-103.1). 
For three of these dogs, follow-up was limited to the fact that the dog was alive with a 
presumed good quality of life.  Detailed information was available to grade outcome in 
22 of these dogs (see table 9). One dog with an excellent outcome had mild visual 
impairment following post-operative blindness. One dog with a poor outcome was 
reported to drink a lot and tire easily. One dog with a poor outcome had experienced an 
episode of pyrexia of unknown origin and a separate episode of chronic diarrhoea. The 
dog was also considered to have some behavioural abnormalities.  Neither dog with a 
poor outcome was on any medical management. The owners of all 22 dogs felt that their 
dogs subjectively had a good quality of life. Two of these dogs were documented to have 
died or been euthanased within two months of their follow-up, one due to gastric 
dilation and volvulus (GDV) and one due to suspected pulmonary neoplasia.  
Ten dogs (20.8%) were confirmed to have died or been euthanatized prior to follow-up. 
Three dogs died because of non-CPSS related causes including one haemoabdomen, one 
liver mass resection and one dogfight. Four dogs were euthanatized for CPSS or 
suspected CPSS related causes; two dogs due to on-going clinical signs, one dog due to 
aggression (presumed related to hepatic encephalopathy) and one dog due to liver 
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disease. The cause of death was unknown in three dogs. The time from surgery to death 
was available for four dogs with a median of 68.7 months (range 7.8-105.5).   
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Discussion 
We have described the short and long-term outcome for 55 dogs with IHCPSS treated 
with suture ligation in one or two surgeries. IHCPSS are technically more challenging 
than EHCPSS due to the location of the CPSS within the liver parenchyma. Therefore, 
intra-operative complications are a major concern with haemorrhage reported in 6.7% 
to 33.1% of dogs in other studies (Komtebedde et al. 1991, Hunt et al. 1996, White et al. 
1998). In the study reported here four dogs (7.3%) suffered haemorrhage during 
IHCPSS dissection at first surgery, none of which resulted in intra-operative mortality or 
ultimately precluded shunt attenuation. The overall rate of intra-operative 
complications at first surgery was 14.5%, which is similar to that reported for 
endovascular treatment, with major intra-operative complications in 3% and minor in 
12% of dogs (Weisse et al. 2014). However, the differences in the procedures and 
therefore the type of complications seen make direct comparison difficult.  
 
Previous studies have reported post-operative complication rates of 11.8-77% for 
suture ligation, 9.1-22.2% for ameroid constrictor placement and 54.5% for cellophane 
banding (Komtebedde et al. 1991, Hunt et al. 1996, Papazoglou et al. 2002, Hunt et al. 
2004, Bright et al. 2006, Mehl et al. 2007). We found a post-operative complication rate 
at first surgery of 43.6%. Complications vary widely in type and severity and it is 
challenging to make direct comparisons between studies. The most common type of 
post-operative complication was categorized as Portal Hypertension / Gastrointestinal 
seen in 25.5% of dogs. These complications were grouped together as the underlying 
cause was not always clear. Four dogs (7.3%) suffered mild to moderate, self-limiting 
post-operative ascites.  This finding is an expected sequel of acute CPSS attenuation and 
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therefore could be considered a routine occurrence rather than a complication (Berent 
and Tobias 2012). However, it was included for completeness.  
 
The current study had a post-operative mortality rate at first surgery of 10.9%. This is 
comparable with previously reported rates of 5.9-22.6% for suture ligation, 0-9.1% for 
ameroid constrictor placement, 27.3% for cellophane bands and 0% for hydraulic 
occluder placement, particularly as many of these are relatively small studies 
(Komtebedde et al. 1991, Hunt et al. 1996, White et al. 1998, Papazoglou et al. 2002, 
Hunt et al. 2004, Adin et al. 2006, Bright et al. 2006, Mehl et al. 2007). However, these 
results are not as good as those reported for endovascular treatment of IHCPSS with a 
post-operative complication rate of 14% and a post-operative mortality rate of 5.3% 
(Weisse et al. 2014). Nevertheless, we should be cautious in making direct comparisons 
between studies due to wide variation in study design and clinical variables. Of the six 
dogs that died at first surgery, two had gastroduodenal ulceration confirmed at post-
mortem, two had severe gastrointestinal haemorrhage suggestive of ulceration and two 
had suspected portal hypertension (one possibly related to a portal thrombus). Dogs 
with IHCPSS seem to be predisposed to gastrointestinal ulceration (Weisse et al. 2014). 
It is unclear whether the fatal post-operative complications seen in the current study 
relate to pre-existing GI ulceration, post-operative portal hypertension, the use of peri-
operative NSAIDs earlier on in the cohort, or a combination of these factors. 
 
Several studies have suggested that dogs with IHCPSS and EHCPSS treated with partial 
attenuation could benefit from repeat surgery to achieve complete attenuation 
(Hottinger et al. 1995, White et al. 1998, Burton and White 2001, Lee et al. 2006). In one 
study the outcome was improved for a proportion of IHCPSS dogs following an 
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additional procedure (White et al. 1998). The current study is the first to report a large 
cohort of IHCPSS dogs treated routinely in this manner. In common with previous 
reports, a minority of dogs (18.2%) could tolerate acute complete attenuation at first 
surgery. Repeat surgery was recommended in all dogs that survived a partial 
attenuation at first surgery, regardless of apparent response. Most of these dogs, 84.6%, 
had a second surgery and this was associated with a reduced rate of complications 
(21.2%) compared to the first surgery and mortality in one dog with MAS (3.0%).  
When both first and second surgeries are taken together this cohort of dogs had a 
mortality rate of 7/55 dogs (12.7%). Of the dogs that could not tolerate a complete 
attenuation at first surgery, repeat surgery allowed complete attenuation in 81.8%, 
including three dogs that had progressed to complete attenuation spontaneously. 
Overall, 77.1% of surviving dogs had complete attenuation of their shunt in one or two 
surgeries. Despite this, two of these dogs were subsequently identified to have 
persistent shunting and full attenuation was achieved at an additional surgery. In 
addition, two dogs were subsequently documented to have developed MAS on follow-up 
imaging. Overall, persistent shunting was demonstrated or suspected in 27.1% dogs 
(13/48). A limited number of dogs had follow-up imaging and therefore the exact rate 
of persistent shunting is unknown and may have been underestimated. However, this 
rate of persistent shunting compares well with a study of the use of ameroid 
constrictors in dogs with IHCPSS that identified persistent shunting on scintigraphy in 
43% of dogs (Mehl et al. 2007). The true significance of persistent shunting is unclear. 
In EHCPSS dogs treated with ameroid constrictors those with a negative post-operative 
scintigraphy scans were >10 times more likely to experience a successful outcome (Falls 
et al. 2013). Intuitively dogs that achieve a complete attenuation without persistent 
shunting should have a better outcome, although this is unproven. Our data supports 
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the concept that repeat surgery markedly increases the proportion of dogs that achieve 
a complete attenuation and therefore reduces the proportion of dogs with persistent 
shunting compared with partial ligation alone and potentially the use of ameroid 
constrictors.  
 
The current study focused on the short-term outcome of suture ligation of IHCPSS. 
However, long-term follow-up was available for some dogs with IHCPSS as part of 
another study validating a HRQOL questionnaire in a large group of dogs with EHCPSS 
and IHCPSS and follow-up was also obtained for dogs that were not part of that study 
(unpublished data). Several studies have reported the long-term follow up of dogs 
treated for IHCPSS, typically assessing outcome by simple owner assessment, although 
the wide variations in the precise definition of a successful outcome, the data reported 
and the follow-up times makes direct comparison challenging. In a large study of 
endovascular occlusion 19% of dogs had a poor outcome with continued or worsening 
clinical signs despite medical management or surgical related death at a median of 32 
months post-treatment (Weisse et al. 2014). In two studies of ameroid constrictor 
placement a poor outcome, with euthanasia due to persistence or recurrent clinical 
signs was reported in 12.5-30% of dogs at an average of 28.5-38.3 months post-surgery 
(Bright et al. 2006, Mehl et al. 2007). In three studies of suture ligation 0-16.3% of dogs 
had a poor outcome with recurrent or persistent signs and / or shunting at an average 
of 18-50 months post-surgery (White et al. 1998, Kummeling et al. 2004, Mehl et al. 
2007). We assessed the long-term outcome of 22 dogs alive at a median time of 29 
months post-operatively. Twenty of these 22 dogs (90.9%) had an excellent or fair 
outcome with a poor outcome in two dogs (9.1%). Additionally, a further three dogs had 
an apparently good outcome but without sufficient detail to categorise this further. This 
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overall outcome is very good and compares favourably with other techniques, although 
detailed follow-up was only available for 45.8% of the dogs in our study. Overall, 14/17 
dogs (82.4%) that had complete attenuation of their shunt had an excellent outcome in 
comparison with 1/5 dogs (20%) that had documented or suspected persistent 
shunting. Although, the number of dogs with persistent shunting is small this data does 
suggest that dogs with complete attenuation and no persistent shunting are more likely 
to have an excellent long term outcome. This would support our recommendation for 
follow-up surgery in dogs with persistent shunting. 
 
We explored the possible association between age, study period and use of NSAIDs with 
mortality following first surgery. Due to the small number of dogs and the retrospective 
nature of the study it was not considered appropriate to statistically analyse the data. 
Future, prospective studies may want to explore these factors in more detail. 
Interestingly, dogs that died during the postoperative period were younger than those 
that survived. It is not clear why that may be the case. As most of the dogs died due to 
complications related to GI bleeding or portal hypertension it is not clear why this 
would be. It is possible that older dogs are more at risk for GI bleeding but this remains 
unproven. The mortality rate was greater in the first part of the study period. This 
apparent improvement could have related to greater experience in determining the 
degree of attenuation and thus a reduced risk of portal hypertension. This could also 
have been associated with general improvements in the anaesthetic and postoperative 
management of these dogs over time, although the study did not look at these aspects 
specifically. Mortality at first surgery seemed to be associated with the use of NSAIDs. 
All four of the dogs that died because of confirmed or suspected gastroduodenal 
ulceration had received NSAIDs post-operatively. NSAIDs are a risk factor for 
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gastrointestinal ulceration due to their effect on prostaglandin synthesis and gastric 
mucosal integrity (Stanton and Bright 1989, Cariou et al. 2009b). As previously 
mentioned dogs with IHCPSS seem to be predisposed to gastrointestinal ulceration 
(Weisse et al. 2014).  Therefore, the use of NSAIDs in these dogs may have contributed 
to these complications. There were no complications or mortality related to 
gastrointestinal haemorrhage at second surgery, despite the use of NSAIDs. The authors 
believe that this is because all dogs undergoing repeat surgery had previously had a 
partial shunt ligation and therefore their portal blood flow and hence liver function 
should have been improved. This presumably makes them less vulnerable to surgical 
complications, particularly those that could have been precipitated by NSAID use. The 
authors no longer use NSAIDs in dogs with IHCPSS or EHCPSS.  
 
The current study has several limitations, primarily due to its retrospective nature. 
Dogs were all operated on at a single centre and over a long period of time.  
Importantly, a proportion of dogs (27.1%) were lost to long-term follow-up. 
Determining the long-term outcome of dogs treated for IHCPSS is challenging, partly 
due to the lack of a ‘gold standard’ assessment method. A more comprehensive follow-
up with owner assessment of quality of life, dynamic bile acids and imaging studies to 
detect persistent shunting, in all dogs, would have strengthened the findings of our 
study. A prospective study looking at the long-term outcome of dogs surgically treated 
for IHCPSS would allow firmer conclusions to be drawn. 
 
This study demonstrates that complete suture attenuation of IHCPSS in one or two 
surgeries is associated in a good long-term outcome. For dogs that could not tolerate a 
complete ligation at first surgery, repeat surgery was associated with a lower rate of 
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complications and a good rate of complete attenuation. The long-term outcome was 
excellent in a high proportion (82.4%) of dogs that had complete attenuation in one or 
two surgeries, compared to those with persistent shunting where a minority (20%) had 
an excellent outcome. Further work is needed to clarify the exact significance of 
persistent shunting on long-term outcome and quality of life.  
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Figure Legends 
Figure 1: Flow diagram showing the short-term follow-up and second surgery in dogs initially treated with partial ligation of an 
intrahepatic congenital portosystemic shunt (IHCPSS). * Despite complete ligation of their CPSS, two dogs were subsequently identified 
to have persistent flow through their CPSS. Both dogs had full attenuation achieved in an additional surgery. In addition, multiple 
acquired shunts were subsequently identified on imaging in two dogs.
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Sex Male entire 
21 (38.2%) 
Male neutered 
7 (12.7%) 
Female entire 
25 (45.5%) 
Female neutered 
2 (3.6%) 
Age 
 
Median 7.1 months (range 2.4-38.2) 
Weight 
 
Median 17.3kg (range 3.1-50.0) 
Breed Labrador 15 
Crossbreed, Golden Retriever 5 per breed 
Border Collie, Border Terrier, Cavalier King Charles Spaniel, German Shepherd Dog, Samoyed, 
Staffordshire Bull terrier 
2 per breed 
Basset Hound, Beagle, British Bulldog, Cocker Spaniel, Flat Coat Retriever, Grand Basset Griffon 
Vendeen, Great Dane, Hovawort, Irish Water Spaniel, Irish Wolfhound, Labradoodle, Lurcher, 
Newfoundland, Old English Sheepdog, Pyrenean Mastiff, Rhodesian Ridgeback, St. Bernard, 
Weimaraner 
1 per breed 
Duration of clinical 
signs prior to surgery 
Median 49 days (range 12-289) 
Medical management 
prior to surgery (all 
dogs) 
Prescription diet 
47 (85.5%) 
Antibiotics 
51 (92.7%) 
Lactulose 
54 (98.2%) 
Duration of medical 
management  
Median 25 days (range 6-289) 
Improvement following 
medical management 
Good 
36 (65.5%) 
Moderate 
17 (30.9%) 
Poor  
2 (3.6%) 
Pre-prandial bile acids 
/  mo/l 
Measured in 46 
Median 89.5 (range 3.4-614.2) 
Postprandial bile acids 
/  mo/l 
Measured in 45 
Median 207.7 (range 19.7-668.0) 
Table 1: Signalment data and pre-surgical information for 55 dogs undergoing suture ligation for the treatment of an intrahepatic 
congenital portosystemic shunt (IHCPSS)  
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Intrahepatic CPSS 
morphology 
Left division 
26 (47.3%) 
Central division 
14 (25.4%) 
Right division 
15 (27.3%) 
Degree of attenuation 
tolerated 
Partial ligation 
45 (81.8%) 
Complete ligation 
10 (18.2%) 
Suture material used Polypropylene 
53 (96.4%) 
Silk 
1 (1.8%) 
Silk and polypropylene 
1 (1.8%) 
NSAIDs given intra or 
postoperatively 
No 
42 (76.4%) 
Yes 
13 (23.6%) 
Table 2: Details of surgical variables for 55 dogs undergoing suture ligation for the treatment of an intrahepatic congenital 
portosystemic shunt (IHCPSS). 
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Complication 
classification 
Number of 
dogs with 
complications 
(%) 
Signalment Shunt 
morphology 
Degree of 
attenuation 
Complication details Mortality  
Neurological 5 /55 (9.1%) Male entire, 11.8-month-
old, Cavalier King Charles 
Spaniel 
Central Partial Several seizures post-operatively – treated with 
phenobarbitone and potassium bromide. 
0 
Female entire, 7.4-
month-old, Old English 
Sheepdog 
Left Complete Altered mentation and ataxia – treated with 
phenobarbitone.* 
Male entire, 7.1-month-
old, Grand Basset Griffon 
Vendeen 
Left Partial Mild facial twitching – treated with levetiracetam. 
Male neutered, 29.1-
month-old, Beagle 
Central Complete Suffered a seizure post-operatively (although had seizure 
prior to surgery) – treated with phenobarbitone and 
continued levetiracetam. 
Female entire, 10.1-
month-old, Labrador 
Central Complete Ataxia, depression and blindness – treated with 
phenobarbitone. 
Portal 
Hypertension / 
Gastrointestinal 
14/55 (25.5%) Male entire, 4.3-month-
old, Flat Coat Retriever 
Left Partial Severe haematomesis, melena, hypovolaemic shock – 
exploratory laparotomy, no obvious portal hypertension – 
died. Post-mortem - severe gastrointestinal haemorrhage. 
6 
Male neutered, 38.2-
month-old, Border Collie 
Right Partial Acute hypotension and hypovolaemic shock – exploratory 
laparotomy, perforated gastric ulcer, further gastric 
ulceration and septic peritonitis – euthanasia.  No post-
mortem. 
Male entire, 14.4-month-
old, Labrador 
Central Partial Regurgitation followed by two serious episodes of 
gastrointestinal haemorrhage – euthanasia. Post mortem 
showed duodenal ulceration.  
Male entire, 9.2-month-
old, Pyrenean Mastiff 
Central Partial Hypoproteinaemic with ascites and pleural effusion, 
suspected portal hypertension. Respiratory crisis, suspect 
pulmonary thromboembolus – euthanasia.  No post-
mortem. 
Male entire, 5.4-month-
old, Labrador 
Central Partial Mild, self-limiting ascites.‡ 
Male entire, 15.4-month-
old, Labrador 
Left Complete Mild, self-limiting ascites.  
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Female entire, 6.4-
month-old, Labrador 
Left Partial Mild, self-limiting ascites.  
Female entire, 3.4-
month-old, Labrador 
Left Partial Moderate, self-limiting ascites.  
Female entire, 7.4-
month-old, Old English 
Sheepdog 
Left Complete Regurgitation – treated with omeprazole.* 
Female entire, 2.7-
month-old, St. Bernard 
Left Complete Vomiting.† 
Male Entire, 5.4-month-
old, Labrador 
Central Partial Vomiting.‡ 
Male neutered, 17.8-
month-old, Labrador 
Central Partial Vomiting. 
Female entire, 12-month-
old, Bassett Hound 
Left Partial Vomiting. 
Male neutered, 23-
month-old, Irish 
Wolfhound 
Left Partial Discharged without complications, however developed 
haematomesis and melena the following day – supportive 
treatment – died. No post-mortem. 
Female neutered, 24.8-
month-old, Labrador 
Left Partial Discharged without complication, however developed 
vomiting and lethargy the following day. Re-examination 
confirmed hypovolaemic shock and ascites – portal 
thrombus suspected – euthanasia.  No post-mortem. 
Miscellaneous 7/55 (12.7%) Female entire, 9.8-
month-old, German 
Shepherd Dog 
Central Partial Hypotensive post-operatively – treated with two units of 
plasma  
0 
Male entire, 4.4-month-
old, Border Terrier 
Central Complete Mild anaemia post-operatively – received blood transfusion 
Female entire, 2.7-
month-old, St. Bernard 
Left Complete Wound infection – treated with antibiotics.† 
Female entire, 4.5-
month-old, Great Dane 
Right Partial Septic arthritis of elbow – treated with antibiotics and 
drainage. 
Female entire, 3.9-
month-old, Golden 
Retriever 
Right Partial Septic arthritis of stifle – treated with antibiotics. 
Male neutered, 18-
month-old, Rhodesian 
Ridgeback 
Right Partial Immune mediated polyarthritis – responded well to 
analgesia.¶ 
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Table 3: Table showing the details of post-operative complications in 55 dogs undergoing initial suture ligation for the treatment of an 
intrahepatic congenital portosystemic shunt (IHCPSS).  
*¶†‡ Dogs suffered two complications post-operatively. 
  
Male neutered, 18-
month-old, Rhodesian 
Ridgeback 
Right Partial Ventricular premature complexes seen for 24 hours.¶ 
Male entire, 7.1-month-
old, Border Collie 
Left Partial Ventricular tachycardia post-operatively. 
 31 
Time between surgery 
and re-examination 
Median 102 days (range 48-358) 
Improvement following 
surgery 
Good 
25 (69.4%) 
Moderate 
10 (27.8%) 
Poor  
1 (2.8%) 
Medical management at 
re-examination (31/36 
dogs – 86.1%) 
Prescription diet  
30 (83.3%) 
Antibiotics 
17(47.2%) 
Lactulose 
23 (63.9%) 
Pre-prandial bile acids 
/  mo/l  
Measured in 26 
Median 57.6 (range 0.4-291.9) 
Postprandial bile acids 
/  mo/l 
Measured in 27 
Median 172.1 (range 2.7-549.0) 
Table 4: Re-examination information for 36/39 dogs initially treated with partial suture ligation for the treatment of an intrahepatic 
congenital portosystemic shunt (IHCPSS). 
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Time interval between 
surgeries 
Median 103 days (range 48-358) 
Sex distribution at 
second surgery 
Male entire 
10 (30.3%) 
Male neutered 
3 (9.1%) 
Female entire 
20 (60.6%) 
Female neutered 
 (0%) 
Age at second surgery Median 9.5 months (range 6.4-26.4) 
Weight at second 
surgery 
Median 20.7kg (range 5.1-45.7) 
 
Breeds represented at 
second surgery 
Labrador 10 
Crossbreed, Golden Retriever 5 
Golden Retriever 3 
German Shepherd Dog, Staffordshire Bull terrier 2 per breed 
Basset Hound, Border Terrier, British Bulldog, Cavalier King Charles Spaniel, Cocker Spaniel, 
Grand Basset Griffon Vendeen, Great Dane, Hovawort, Irish Water Spaniel, Labradoodle, 
Rhodesian Ridgeback 
1 per breed 
Intrahepatic CPSS 
morphology at second 
surgery 
Left division 
16 (48.5%) 
Central division 
6 (18.2%) 
Right division 
11 (33.3%) 
Degree of attenuation 
tolerated 
Complete ligation 
25 (75.8%) 
Partial ligation 
2 (6.1%) 
Progressed to full 
attenuation (no flow on 
portovenography) 
3 (9.1%) 
Multiple acquired shunts 
had developed 
3 (9.1%) 
NSAIDs given intra or 
postoperatively 
No 
23 (69.7%) 
Yes 
10 (30.3%) 
Table 5: Further information for 33 dogs undergoing a second surgery following initial partial suture ligation for the treatment of an 
intrahepatic congenital portosystemic shunt (IHCPSS). 
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Complication 
Classification 
Number of 
dogs with 
complications 
(%) 
Signalment Shunt 
morphology 
Degree of 
attenuation 
Complication Details Mortality 
Neurological 2 (6.1%) Male entire, 6.5-
month-old, 
Labrador 
Left Multiple acquired 
shunts had 
developed 
Several seizures postoperatively – treated with 
phenobarbitone. 
1 
Female entire, 
13.9-month-old, 
German 
Shepherd dog 
Central Multiple acquired 
shunts had 
developed 
Discharged without complications. However, developed 
neurological signs later that day Re-examined by referring 
veterinary surgeon – euthanasia. 
Miscellaneous 6 (18.2%) Male neutered, 
12.4-month-old, 
Labrador 
Left Complete Urinary tract infection– responded well to antibiotics. 0 
Female entire, 
10.9-month-old, 
Cavalier King 
Charles Spaniel 
Left Complete Diarrhoea. 
Female entire, 
15.8-month-old, 
British Bulldog 
Central Progressed to full 
attenuation (no flow 
on portovenography) 
Pyrexia and neutrophilic abdominal effusion, presumed post-
operative peritonitis – treated successfully with antibiotics. 
Female entire, 
10.9-month-old, 
crossbreed 
Right Complete Haemorrhage from ovarian pedicle following 
ovariohysterectomy – blood transfusion, exploratory 
laparotomy and re-ligation. 
Female entire, 
11.6-month-old, 
Labrador 
Left Partial (complete 
ligation prevented by 
adhesions) 
Mild bleeding from abdominal wound – resolved with 
supportive treatment. 
Male entire, 7.1-
month-old, 
Grand Basset 
Griffon Vendeen 
Left Complete Mild scrotal swelling after castration. 
Table 6: Table showing the details of post-operative complications in 33 dogs undergoing repeat surgery for the attenuation of an 
intrahepatic congenital portosystemic shunt IHCPSS.  
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Time between surgery 
and re-examination 
Median 121.5 days (range 78-388) 
Improvement following 
surgery 
Good 
6 (75.0%) 
Moderate 
1 (12.5%) 
Poor  
1 (12.5%) 
Pre-prandial bile acids 
/  mo/l  
Measured in 5 
Median 14.9 (range 1.2-274.0) 
Postprandial bile acids 
/  mo/l 
Measured in 5 
Median 22.3 (range 1.7-503.1) 
Table 7: Re-examination information for 8/10 dogs (80%) initially treated with complete suture ligation for the treatment of an 
intrahepatic congenital portosystemic shunt (IHCPSS). 
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Time between surgery 
and re-examination 
Median 105.5 days (range 32-180) 
Improvement following 
surgery 
Good 
11 (78.6%) 
Moderate 
3 (21.4%) 
Poor  
0 (0%) 
Pre-prandial bile acids 
/  mo/l  
Measured in 11 
Median 40.6 (range 2.1-237.1) 
Postprandial bile acids 
/  mo/l 
Measured in 9 
Median 183.3 (range 3.3-378.0) 
Table 8: Re-examination information following second surgery for 14/32 dogs (43.8%) initially treated with partial suture ligation for 
the treatment of an intrahepatic congenital portosystemic shunt (IHCPSS).  
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Time between surgery 
and follow-up 
Median 29 months (range 7.4-103.1) 
Overall outcome Excellent 
15 (68.2%) 
Fair 
5 (22.7%) 
Poor  
2 (9.1%) 
Surgical treatment 
and overall outcome  
Complete ligation at 
1st surgery  
 
 
 
4 (18.2%) 
 
Excellent - 4 
Fair - 0 
Poor - 0 
Partial ligation at 1st 
surgery and no repeat 
surgery 
 
 
2 (9.1%) 
 
Excellent - 0 
Fair - 2 
Poor - 0 
Complete ligation in 
two procedures 
 
 
 
12 (54.5%) 
 
Excellent - 9 
Fair - 2 
Poor - 1 
Progressed to 
complete attenuation 
following partial 
ligation 
 
1 (4.5%) 
 
Excellent - 1 
Fair - 0 
Poor - 0 
Development of 
multiple acquired 
shunts documented* 
 
 
3 (13.6%) 
 
Excellent - 1 
Fair - 1 
Poor - 1 
Overall outcome 
based on surgical 
outcome 
Complete attenuation of shunt (in one or two surgeries) 
 
17 (77.3%) 
 
Excellent - 14 (82.4%) 
Fair – 2 (11.7%) 
Poor – 1 (5.9%) 
Documented or presumed persistent shunting due to 
incomplete attenuation or multiple acquired shunts 
5 (22.7%) 
 
Excellent – 1 (20%) 
Fair – 3 (60%) 
Poor – 1 (20%) 
Pre-prandial bile 
acids /  mo/l  
Measured in 9 
Median 11.5 (range 0.7-257.4) 
Postprandial bile 
acids /  mo/l 
Measured in 9 
Median 130.5 (range 2.3-381.8) 
Table 9: Long-term follow-up information for 22 dogs surgically treated for an intrahepatic congenital portosystemic shunt (IHCPSS) 
that were alive at the time of the study. 
*Two documented on portovenography at repeat surgery following partial ligation and one documented on ultrasound following 
complete ligation in two procedures. 
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